{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:20:16Z","timestamp":1789827616796,"version":"4.0.1"},"reference-count":100,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>To determine treatment seeking behaviour in those with opioid use disorder (OUD) in the high-income countries.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Five databases were searched in November 2019 for quantitative studies that reported OUD treatment seeking behaviour. Data analysis involved determining an overall pooled proportion estimate of treatment seeking behaviour for the two base groups, lifetime treatment and past 12-month or less treatment using the IVhet effect model. Subgroup analysis included heroin OUD, prescription OUD and general OUD. The sensitivity analysis included removal of outliers, separating adults and adolescents and the metaXL sensitivity analysis (studies are excluded if outside the pooled proportion confidence interval of the base case). Systematic review Prospero database registration number [CRD42020159531].<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>There were 13 quantitative studies included in the systematic review, with all studies being from the United States of America (USA). IVhet models showed that 40% (95% CI: 23%, 58%) and 21% (95% CI: 16%, 26%) sought treatment in their lifetime and past 12 months respectively. Sub-group analysis found that lifetime treatment seeking for prescription OUD, 29% (95% CI: 27%, 31%), was less than for heroin plus combined OUD, 54% (95% CI: 26%, 82%). Most of the pooled results had high heterogeneity statistics except for results of lifetime treatment seeking for prescription OUD and past 12-month treatment seeking for prescription OUD.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>All included studies in this meta-analysis were from the USA and indicate modest levels of treatment seeking for those with OUD. In particular, this review found that in the USA one in five people with OUD sought OUD treatment in the previous 12 months and two in five people with OUD sought OUD treatment in their lifetime. Further research is urgently required to explore the barriers and facilitators that can improve this low treatment seeking in those with OUD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0258620","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T18:00:08Z","timestamp":1634320808000},"page":"e0258620","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Treatment-seeking behaviour among people with opioid use disorder in the high-income countries: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5779-0264","authenticated-orcid":true,"given":"Natasha","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishani","family":"Majmudar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maree","family":"Teesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Mihalopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"issue":"12","key":"pone.0258620.ref001","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"5","author":"L Degenhardt","year":"2018","journal-title":"The Lancet Psychiatry"},{"issue":"1","key":"pone.0258620.ref002","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"L Degenhardt","year":"2011","journal-title":"Addiction"},{"issue":"9651","key":"pone.0258620.ref003","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"BM Mathers","year":"2008","journal-title":"The Lancet"},{"issue":"9791","key":"pone.0258620.ref004","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"PK Nelson","year":"2011","journal-title":"The Lancet"},{"issue":"6","key":"pone.0258620.ref005","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1017\/S0033291711002145","article-title":"Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions","volume":"42","author":"SS Martins","year":"2012","journal-title":"Psychological Medicine"},{"issue":"3","key":"pone.0258620.ref006","doi-asserted-by":"crossref","first-page":"e180558","DOI":"10.1001\/jamanetworkopen.2018.0558","article-title":"Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use","volume":"1","author":"TNA Winkelman","year":"2018","journal-title":"JAMA network open"},{"issue":"4","key":"pone.0258620.ref007","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/ajad.12188","article-title":"Health-related quality of life among prescription opioid-dependent patients: Results from a multi-site study","volume":"24","author":"ML Griffin","year":"2015","journal-title":"American Journal on Addictions"},{"issue":"5","key":"pone.0258620.ref008","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.drugpo.2010.01.010","article-title":"Quality of life among opiate-dependent individuals: A review of the literature","volume":"21","author":"J De Maeyer","year":"2010","journal-title":"International Journal of Drug Policy"},{"key":"pone.0258620.ref009","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugalcdep.2019.03.004","article-title":"Association of current and past opioid use disorders with health-related quality of life and employment among US adults","volume":"199","author":"TG Rhee","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"pone.0258620.ref010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-Assisted Treatment With Methadone: Assessing the Evidence.","author":"CA Fullerton","year":"2014","journal-title":"Psychiatric Services"},{"key":"pone.0258620.ref011","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"L Sordo","year":"2017","journal-title":"BMJ-BRITISH MEDICAL JOURNAL"},{"issue":"12","key":"pone.0258620.ref012","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.addbeh.2011.07.033","article-title":"Treatment use and barriers among adolescents with prescription opioid use disorders","volume":"36","author":"L-T Wu","year":"2011","journal-title":"Addictive Behaviors."},{"key":"pone.0258620.ref013","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drugalcdep.2015.08.026","article-title":"Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions\u2013III","volume":"156","author":"BT Kerridge","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"pone.0258620.ref014","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.drugalcdep.2007.11.018","article-title":"Opioid use disorder in the United States: insurance status and treatment access","volume":"94","author":"WC Becker","year":"2008","journal-title":"Drug And Alcohol Dependence"},{"issue":"6","key":"pone.0258620.ref015","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4088\/JCP.15m10386","article-title":"Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States","volume":"77","author":"TD Saha","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"14","key":"pone.0258620.ref016","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jama.2015.10345","article-title":"Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States, 2004\u20132013","volume":"314","author":"B Saloner","year":"2015","journal-title":"JAMA"},{"key":"pone.0258620.ref017","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States","volume":"169","author":"L-T Wu","year":"2016","journal-title":"Drug And Alcohol Dependence"},{"issue":"2","key":"pone.0258620.ref018","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/08897077.2019.1573208","article-title":"Adults who misuse opioids: Substance abuse treatment use and perceived treatment need","volume":"40","author":"NG Choi","year":"2019","journal-title":"Substance Abuse."},{"key":"pone.0258620.ref019","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jsat.2018.07.011","article-title":"U.S. adults with opioid use disorder living with children: Treatment use and barriers to care","volume":"93","author":"KA Feder","year":"2018","journal-title":"Journal Of Substance Abuse Treatment"},{"issue":"6","key":"pone.0258620.ref020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/00952990.2010.503824","article-title":"Service use and barriers to care among heroin users: results from a national survey","volume":"36","author":"O Mowbray","year":"2010","journal-title":"The American Journal Of Drug And Alcohol Abuse"},{"issue":"5","key":"pone.0258620.ref021","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/09595230500286039","article-title":"The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study [ATOS]","volume":"24","author":"J Ross","year":"2005","journal-title":"Drug And Alcohol Review"},{"issue":"11","key":"pone.0258620.ref022","first-page":"858","article-title":"The treatment gap in mental health care","volume":"82","author":"R Kohn","year":"2004","journal-title":"Bulletin of the World health Organization"},{"issue":"7716","key":"pone.0258620.ref023","first-page":"332","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"D Moher","year":"2009","journal-title":"BMJ: British Medical Journal"},{"key":"pone.0258620.ref024","volume-title":"World Economic Situation and Prospects","author":"United Nations","year":"2019"},{"issue":"9719","key":"pone.0258620.ref025","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage","volume":"375","author":"BM Mathers","year":"2010","journal-title":"The Lancet"},{"issue":"4","key":"pone.0258620.ref026","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11606-007-0129-0","article-title":"Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients","volume":"22","author":"BA Moore","year":"2007","journal-title":"Journal of general internal medicine"},{"issue":"9","key":"pone.0258620.ref027","doi-asserted-by":"crossref","first-page":"e0162226","DOI":"10.1371\/journal.pone.0162226","article-title":"The Effectiveness of Cognitive Bias Modification Interventions for Substance Addictions: A Meta-Analysis","volume":"11","author":"IA Cristea","year":"2016","journal-title":"PloS one"},{"issue":"Pt A","key":"pone.0258620.ref028","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cct.2015.05.009","article-title":"Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model","volume":"45","author":"SA Doi","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"pone.0258620.ref029","volume-title":"MetaXL user guide","author":"J Barendregt","year":"2016"},{"key":"pone.0258620.ref030","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JPT Higgins","year":"2019","edition":"2"},{"key":"pone.0258620.ref031","volume-title":"Critical appraisal checklist for analytical cross sectional studies","author":"Joanna Briggs Institute","year":"2017"},{"key":"pone.0258620.ref032","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2018.04.004","article-title":"Patient predictors of substance use disorder treatment initiation in primary care","volume":"90","author":"AJ Ober","year":"2018","journal-title":"Journal Of Substance Abuse Treatment"},{"issue":"1","key":"pone.0258620.ref033","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2008.10.015","article-title":"Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder.","volume":"101","author":"GA Subramaniam","year":"2009","journal-title":"Drug And Alcohol Dependence"},{"issue":"1","key":"pone.0258620.ref034","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.drugalcdep.2012.12.013","article-title":"Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study","volume":"131","author":"C Blanco","year":"2013","journal-title":"Drug And Alcohol Dependence"},{"key":"pone.0258620.ref035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2018.12.006","article-title":"Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey","volume":"98","author":"P Novak","year":"2019","journal-title":"Journal Of Substance Abuse Treatment"},{"issue":"3","key":"pone.0258620.ref036","first-page":"177","article-title":"Delay and failure in treatment seeking after first onset of mental disorders in the world Health Organization\u2019s World Mental Survey Initiative","volume":"6","author":"PS Wang","year":"2007","journal-title":"World Psychiatry"},{"key":"pone.0258620.ref037","author":"World Health Organization","year":"2004","journal-title":"WHO\/UNODC\/UNAIDS position paper: Substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS prevention"},{"issue":"12","key":"pone.0258620.ref038","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s11606-020-06251-w","article-title":"Complex Persistent Opioid Dependence with Long-term Opioids: a Gray Area That Needs Definition, Better Understanding, Treatment Guidance, and","volume":"35","author":"A Manhapra","year":"2020","journal-title":"Policy Changes. Journal of General Internal Medicine"},{"issue":"5","key":"pone.0258620.ref039","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","author":"S Nielsen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"pone.0258620.ref040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jsat.2014.06.006","article-title":"Buprenorphine pharmacotherapy and behavioral treatment: Comparison of outcomes among prescription opioid users, heroin users and combination users","volume":"48","author":"S Nielsen","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"pone.0258620.ref041","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1465-3362.2011.00302.x","article-title":"Pharmaceutical opioid analgesic and heroin dependence: How do treatment-seeking clients differ in Australia?","volume":"30","author":"S Nielsen","year":"2011","journal-title":"Drug & Alcohol Review"},{"key":"pone.0258620.ref042","first-page":"671","article-title":"Prevalence of Pain Among Nonmedical Prescription Opioid Users in Substance Use Treatment Populations: Systematic Review and Meta-analyses","volume":"16","author":"A Lusted","year":"2013","journal-title":"Pain Physician"},{"issue":"2","key":"pone.0258620.ref043","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11469-016-9719-6","article-title":"Stigma and Social Support in Pharmaceutical Opioid Treatment Populations: a Scoping Review","volume":"15","author":"S Cooper","year":"2017","journal-title":"International Journal of Mental Health & Addiction"},{"key":"pone.0258620.ref044","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.drugalcdep.2015.02.004","article-title":"Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011","volume":"149","author":"S Nielsen","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"pone.0258620.ref045","doi-asserted-by":"crossref","first-page":"9724371","DOI":"10.1155\/2017\/9724371","article-title":"The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain","volume":"2017","author":"J Sheng","year":"2017","journal-title":"Neural Plast"},{"issue":"1","key":"pone.0258620.ref046","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/204946371000400103","article-title":"Depression and Anxiety in Pain","volume":"4","author":"AK Woo","year":"2010","journal-title":"Rev Pain"},{"key":"pone.0258620.ref047","doi-asserted-by":"crossref","first-page":"108651","DOI":"10.1016\/j.drugalcdep.2021.108651","article-title":"Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective","volume":"221","author":"NY Hall","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"pone.0258620.ref048","volume-title":"Over the counter codeine dependence.","author":"S Nielsen","year":"2010"},{"issue":"3","key":"pone.0258620.ref049","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.sapharm.2013.07.006","article-title":"Contested space in the pharmacy: Public attitudes to pharmacy harm reduction services in the West of Scotland","volume":"10","author":"W Gidman","year":"2014","journal-title":"Research in Social and Administrative Pharmacy"},{"issue":"2","key":"pone.0258620.ref050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/j.1440-1614.2000.00715.x","article-title":"Alcohol- and drug-use disorders in Australia: implications of the National Survey of Mental Health and Wellbeing.","volume":"34","author":"M Teesson","year":"2000","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"issue":"8","key":"pone.0258620.ref051","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3109\/00048671003705458","article-title":"Help-seeking for substance use, anxiety and affective disorders among young people: results from the 2007 Australian National Survey of Mental Health and Wellbeing","volume":"44","author":"NJ Reavley","year":"2010","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"key":"pone.0258620.ref052","volume-title":"Drug decriminalization in Portugal: lessons for creating fair and successful drug policies","author":"G. Greenwald","year":"2009"},{"issue":"6","key":"pone.0258620.ref053","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/bjc\/azq038","article-title":"What can we learn from the Portuguese decriminalization of illicit drugs?","volume":"50","author":"CE Hughes","year":"2010","journal-title":"British journal of criminology"},{"key":"pone.0258620.ref054","volume-title":"Germany: Country Drug Report 2017","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2017"},{"issue":"3","key":"pone.0258620.ref055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/02791072.2015.1056891","article-title":"Stigma towards Marijuana Users and Heroin Users","volume":"47","author":"SA Brown","year":"2015","journal-title":"Journal of Psychoactive Drugs"},{"key":"pone.0258620.ref056","article-title":"Measurement invariance and psychometric properties of Perceived Stigma toward People who use Substances [PSPS] among three types of substance use disorders: Heroin, amphetamine, and alcohol","volume":"216","author":"C-C Chang","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"pone.0258620.ref057","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1465-3362.2011.00406.x","article-title":"A pilot study examining perceived rejection and secrecy in relation to illicit drug use and associated stigma","volume":"31","author":"JJ Palamar","year":"2012","journal-title":"Drug & Alcohol Review"},{"issue":"2","key":"pone.0258620.ref058","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/15360288.2015.1037521","article-title":"The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response","volume":"29","author":"AB Kanouse","year":"2015","journal-title":"Journal of pain & palliative care pharmacotherapy"},{"issue":"3","key":"pone.0258620.ref059","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/02791072.2012.704591","article-title":"\"Hooked on\" prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients","volume":"44","author":"KM Peavy","year":"2012","journal-title":"Journal of psychoactive drugs"},{"issue":"3","key":"pone.0258620.ref060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.drugalcdep.2005.05.002","article-title":"Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver","volume":"80","author":"T Kerr","year":"2005","journal-title":"Drug And Alcohol Dependence"},{"issue":"14","key":"pone.0258620.ref061","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1081\/JA-120014088","article-title":"Drug user treatment referrals and entry among participants of a needle exchange program","volume":"37","author":"ED Riley","year":"2002","journal-title":"Substance Use & Misuse"},{"key":"pone.0258620.ref062","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drugalcdep.2018.05.027","article-title":"Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine","volume":"190","author":"A Zelenev","year":"2018","journal-title":"Drug And Alcohol Dependence"},{"issue":"4","key":"pone.0258620.ref063","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/ADT.0b013e31815af1bd","article-title":"Factors limiting successful buprenorphine treatment with inner city heroin users: A patient survey","volume":"7","author":"RP Ferguson","year":"2008","journal-title":"Addictive Disorders and their Treatment"},{"issue":"8","key":"pone.0258620.ref064","doi-asserted-by":"crossref","first-page":"e0203262","DOI":"10.1371\/journal.pone.0203262","article-title":"\"They don\u2019t like us\u2026.\": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study","volume":"13","author":"S Kumar","year":"2018","journal-title":"Plos One"},{"key":"pone.0258620.ref065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jsat.2019.01.019","article-title":"Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support","volume":"100","author":"D Muthulingam","year":"2019","journal-title":"Journal Of Substance Abuse Treatment"},{"issue":"2","key":"pone.0258620.ref066","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/ijerph6020787","article-title":"Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities","volume":"6","author":"ND Zaller","year":"2009","journal-title":"International Journal Of Environmental Research And Public Health"},{"issue":"6","key":"pone.0258620.ref067","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.addbeh.2011.01.004","article-title":"Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness","volume":"36","author":"DEA Deering","year":"2011","journal-title":"Addictive Behaviors."},{"issue":"4","key":"pone.0258620.ref068","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1081\/JA-120002807","article-title":"Canadian illicit opiate users\u2019 views on methadone and other opiate prescription treatment: an exploratory qualitative study","volume":"37","author":"B Fischer","year":"2002","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"pone.0258620.ref069","doi-asserted-by":"crossref","DOI":"10.1186\/s13011-016-0085-y","article-title":"Systemic and individual factors in the buprenorphine treatment-seeking process: a qualitative study","volume":"12","author":"VM Hewell","year":"2017","journal-title":"Substance Abuse Treatment, Prevention, And Policy"},{"issue":"1","key":"pone.0258620.ref070","doi-asserted-by":"crossref","DOI":"10.1186\/s12939-018-0787-z","article-title":"Perceived barriers to methadone maintenance treatment among Iranian opioid users","volume":"17","author":"M Khazaee-Pool","year":"2018","journal-title":"International Journal For Equity In Health"},{"issue":"9","key":"pone.0258620.ref071","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3109\/10826084.2011.561905","article-title":"Opiate users\u2019 perceived barriers against attending methadone maintenance therapy: a qualitative study in China","volume":"46","author":"C Lin","year":"2011","journal-title":"Substance Use & Misuse"},{"issue":"5","key":"pone.0258620.ref072","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/09540120903311490","article-title":"Exploring stakeholder perceptions of facilitators and barriers to accessing methadone maintenance clinics in Yunnan Province","volume":"22","author":"MM Philbin","year":"2010","journal-title":"China. AIDS Care"},{"key":"pone.0258620.ref073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-015-0037-2","article-title":"Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden","volume":"12","author":"T Richert","year":"2015","journal-title":"Harm Reduction Journal"},{"key":"pone.0258620.ref074","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jsat.2015.08.007","article-title":"Social and Structural Challenges to Drug Cessation Among Couples in Northern Mexico: Implications for Drug Treatment in Underserved Communities","volume":"61","author":"AR Bazzi","year":"2016","journal-title":"Journal Of Substance Abuse Treatment"},{"issue":"6","key":"pone.0258620.ref075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/ADM.0000000000000436","article-title":"The More Things Change: Buprenorphine\/naloxone Diversion Continues While Treatment Remains Inaccessible","volume":"12","author":"JJ Carroll","year":"2018","journal-title":"Journal Of Addiction Medicine"},{"key":"pone.0258620.ref076","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2016.03.003","article-title":"The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment","volume":"66","author":"MJ Bojko","year":"2016","journal-title":"Journal Of Substance Abuse Treatment"},{"issue":"4","key":"pone.0258620.ref077","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/10826084.2010.501655","article-title":"Heroin use, dependence, and attitudes to treatment in non-treatment-seeking heroin users: a pilot study","volume":"46","author":"A Dean","year":"2011","journal-title":"Substance Use & Misuse"},{"issue":"3","key":"pone.0258620.ref078","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit Use of Buprenorphine\/Naloxone Among Injecting and Noninjecting Opioid Users","volume":"5","author":"A Bazazi","year":"2011","journal-title":"Journal of Addiction Medicine"},{"issue":"6","key":"pone.0258620.ref079","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.whi.2017.05.002","article-title":"Initiation and Engagement with Methadone Treatment among Pregnant and Postpartum Women","volume":"27","author":"KM Mattocks","year":"2017","journal-title":"Women\u2019s Health Issues: Official Publication Of The Jacobs Institute Of Women\u2019s Health"},{"issue":"2","key":"pone.0258620.ref080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5055\/jom.2013.0152","article-title":"Consumer attitudes about opioid addiction treatment: a focus group study in New York City","volume":"9","author":"NL Sohler","year":"2013","journal-title":"Journal Of Opioid Management"},{"issue":"1","key":"pone.0258620.ref081","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000320576","article-title":"Barriers to opioid substitution treatment access, entry and retention: a survey of opioid users, patients in treatment, and treating and non-treating physicians","volume":"17","author":"H. St\u00f6ver","year":"2011","journal-title":"European Addiction Research"},{"issue":"3","key":"pone.0258620.ref082","first-page":"255","article-title":"\"Bureaucracy & Beliefs\": Assessing the Barriers to Accessing Opioid Substitution Therapy by People Who Inject Drugs in Ukraine","volume":"22","author":"MJ Bojko","year":"2015","journal-title":"Drugs [Abingdon, England]"},{"issue":"1","key":"pone.0258620.ref083","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugpo.2008.07.004","article-title":"Why don\u2019t out-of-treatment individuals enter methadone treatment programmes?","volume":"21","author":"JA Peterson","year":"2010","journal-title":"The International Journal On Drug Policy"},{"issue":"14","key":"pone.0258620.ref084","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3109\/10826089909039434","article-title":"The street\/treatment barrier: treatment experiences of Puerto Rican injection drug users","volume":"34","author":"J. Porter","year":"1999","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"pone.0258620.ref085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.1994.10472597","article-title":"Drug treatment on demand\u2014not","volume":"26","author":"LD Wenger","year":"1994","journal-title":"Journal Of Psychoactive Drugs"},{"issue":"2","key":"pone.0258620.ref086","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF02287379","article-title":"Access to publicly funded methadone maintenance treatment in two western states","volume":"31","author":"D Deck","year":"2004","journal-title":"The Journal Of Behavioral Health Services & Research"},{"issue":"6","key":"pone.0258620.ref087","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/dar.12268","article-title":"Perceived barriers to utilise methadone maintenance therapy among male injection drug users in rural areas of southern Thailand","volume":"34","author":"R Khampang","year":"2015","journal-title":"Drug And Alcohol Review"},{"key":"pone.0258620.ref088","article-title":"Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder","volume":"10","author":"AD Fox","year":"2015","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"pone.0258620.ref089","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5055\/jom.2006.0006","article-title":"Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver","volume":"2","author":"C Callon","year":"2006","journal-title":"Journal Of Opioid Management"},{"issue":"5","key":"pone.0258620.ref090","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1108\/eb013260","article-title":"VIOLENCE: A BARRIER TO METHADONE MAINTENANCE TREATMENT FOR WOMEN INJECTION DRUG USERS","volume":"16","author":"MS Kelley","year":"1996","journal-title":"International Journal of Sociology & Social Policy"},{"issue":"2","key":"pone.0258620.ref091","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1377\/hlthaff.2019.00309","article-title":"Gaps In Access To Opioid Use Disorder Treatment For Medicare Beneficiaries","volume":"39","author":"SJ Harris","year":"2020","journal-title":"Health affairs [Project Hope]"},{"key":"pone.0258620.ref092","volume-title":"Methadone and buprenorphine for the management of opioid dependence United Kingdom","author":"National Institute for Health and Care Excellence","year":"2007"},{"issue":"3","key":"pone.0258620.ref093","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1024\/2007.03.07","article-title":"Unmet needs and barriers to health-care utilization among young adult, problematic drug users: An exploratory study","volume":"53","author":"E Witteveen","year":"2007","journal-title":"Sucht"},{"issue":"2","key":"pone.0258620.ref094","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000019017","article-title":"Measuring met and unmet need of drug misusers: integration of quantitative and qualitative data","volume":"6","author":"J Fountain","year":"2000","journal-title":"European Addiction Research."},{"issue":"8","key":"pone.0258620.ref095","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3109\/10826089209065582","article-title":"Help-seeking among illicit drug users: Some differences between a treatment and nontreatment sample","volume":"27","author":"R Power","year":"1992","journal-title":"International Journal of the Addictions"},{"issue":"6","key":"pone.0258620.ref096","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1360-0443.1988.tb02592.x","article-title":"Letting the client speak: drug misusers and the process of help seeking","volume":"83","author":"E Oppenheimer","year":"1988","journal-title":"British Journal Of Addiction"},{"issue":"9","key":"pone.0258620.ref097","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/qjmed\/hcx076","article-title":"Codeine use, dependence and help-seeking behaviour in the UK and Ireland: an online cross-sectional survey","volume":"110","author":"A Kimerg\u00e5rd","year":"2017","journal-title":"QJM: Monthly Journal Of The Association Of Physicians"},{"issue":"6","key":"pone.0258620.ref098","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1465-3362.2010.00258.x","article-title":"The Cedar Project: methadone maintenance treatment among young Aboriginal people who use opioids in two Canadian cities","volume":"30","author":"J Yang","year":"2011","journal-title":"Drug And Alcohol Review"},{"issue":"4","key":"pone.0258620.ref099","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/pm\/pny078","article-title":"Concerns and Help-Seeking Among Patients Using Opioids for Management of Chronic Noncancer Pain","volume":"20","author":"B Larance","year":"2019","journal-title":"Pain Medicine [Malden, Mass]"},{"issue":"9201","key":"pone.0258620.ref100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0140-6736(99)00416-X","article-title":"UK and US health-care systems: divided by more than a common language","volume":"355","author":"MM Huw Davies","year":"2000","journal-title":"Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0258620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T18:02:22Z","timestamp":1634320942000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0258620"}},"subtitle":[],"editor":[{"given":"Adam","family":"Todd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":100,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0258620","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]}}}